Press releases | WebDisclosure

Basculer en Français

10964	Companies
240038	Keywords
168782	Articles
129139	Press releases

Home
Press releases

PRESS RELEASE

published on 05/14/2024 at 19:56, 2 years 3 months ago

Voltalia launches its third employee share purchase plan
Voltalia launches its third employee share purchase plan, offering eligible employees the chance to participate in the company's growth. Subscription period opens on May 15, 2024. CEO Sébastien Clerc highlights employees' commitment

Renewable Energies Employee Share Purchase Plan Subscription Period Voltalia CEO Sébastien Clerc
PRESS RELEASE

published on 05/14/2024 at 19:56, 2 years 3 months ago

Voltalia lance son troisième plan d’actionnariat salarié
Voltalia lance son troisième plan d'actionnariat salarié, offrant aux employés éligibles la possibilité d'acheter des actions à conditions attractives. La période de souscription se déroule du 15 au 29 mai 2024

Énergies Renouvelables Souscription Voltalia Plan D'actionnariat Salarié Conditions Attractives
PRESS RELEASE

published on 05/14/2024 at 19:55, 2 years 3 months ago

Air France-KLM announces the successful issuance of new bonds for a total aggregate amount of €650 million
Air France-KLM successfully issues €650 million in new bonds with strong investor demand, expected to be rated BBB- by Fitch and BB+ by S&P

Investor Demand Credit Ratings Air France-KLM Bonds Issuance €650 Million
PRESS RELEASE

published on 05/14/2024 at 19:34, 2 years 3 months ago

Inside Information / News release on accounts, results
MaaT Pharma launches a global offering of approximately 18 million euros to fund R&D activities and expand shareholder base. Current shareholders commit to significant subscriptions

Global Offering MaaT Pharma 18 Million Euros R&D Activities Shareholder Commitments
PRESS RELEASE

published on 05/14/2024 at 19:34, 2 years 3 months ago

Informations privilégiées / Communiqué sur comptes, résultats
MaaT Pharma lance une augmentation de capital de 18 millions d'euros pour financer ses activités de R&D, incluant des essais cliniques aux États-Unis et en Europe

Actionnaires Augmentation De Capital R&D Essais Cliniques MaaT Pharma
PRESS RELEASE

published on 05/14/2024 at 19:30, 2 years 3 months ago

COMMUNIQUÉ DU 14 MAI 2024 RELATIF AU DÉPÔT DU PROJET DE NOTE D'INFORMATION ÉTABLI PAR LA SOCIÉTÉ EN RÉPONSE AU PROJET D'OFFRE PUBLIQUE D'ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ MICROPOLE SA INITIÉE PAR MIRAMAR HOLDING SAS
REGULATED PRESS RELEASE

published on 05/14/2024 at 19:27, 2 years 3 months ago

Assemblée générale 14 mai 2024 - Compte-rendu synthétique, paiement du dividende en actions et résultat des votes
Compte-rendu de l'assemblée générale mixte du 14 mai 2024 de Neoen S.A. : approbation des résolutions, paiement du dividende en actions et détails des votes

Assemblée Générale Resolutions Votes Dividende En Actions Neoen S.A.
PRESS RELEASE

published on 05/14/2024 at 19:15, 2 years 3 months ago

ECS, Inc. is Now Coffman Engineers
Coffman Engineers, Inc. expands its Pacific region capabilities through a strategic partnership with ECS, Inc., leading to increased electrical engineering capacity

Expansion Strategic Partnership Coffman Engineers Inc. Electrical Engineering Pacific Region
PRESS RELEASE

published on 05/14/2024 at 19:00, 2 years 3 months ago

Fraxion and Compu-Tech Forge Strategic Agritech Partnership
Fraxion partners with Compu-Tech to enhance financial efficiency in tree fruit industry through automation and integrations, revolutionizing industry standards

Automation Fraxion Compu-Tech Tree Fruit Industry Financial Efficiency
PRESS RELEASE

published on 05/14/2024 at 18:40, 2 years 3 months ago

ENCAVIS AG: Results for Q1/2024 are, as expected, below the comparative period of the previous year, but still generally in line with plan – Management Board confirms guidance for the full year 2024
ENCAVIS AG reports Q1/2024 results below previous year but in line with plan. Management Board confirms guidance for the full year 2024

Revenue Earnings Encavis AG Management Board Q1/2024 Results

Accesswire

Published on 09/11/2026 at 04:00, 8 hours 44 minutes ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 14 hours 19 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 18 hours 58 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 21 hours 24 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 44 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 11:45, 58 minutes ago

Halfords Group PLC: Result of AGM
Published on 09/11/2026 at 11:43, 1 hour ago

Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 8 minutes ago

EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 13 minutes ago

Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 28 minutes ago

TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050

Les Echos

Published on 09/11/2026 at 07:00, 5 hours 44 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 44 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 5 hours 44 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 44 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 17 hours 14 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE